MedPath

Henry Schein, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

172

FDA:172

Drug Approvals

PRECEDEX

Approval Date
Jun 18, 2025
FDA

Phenylephrine Hydrochloride

Approval Date
Jun 18, 2025
FDA

Hydralazine Hydrochloride

Approval Date
May 20, 2025
FDA

CYANOCOBALAMIN

Approval Date
May 8, 2025
FDA

Atropine Sulfate

Approval Date
Apr 17, 2025
FDA

Diazepam

Approval Date
Apr 4, 2024
FDA

Aminophylline

Approval Date
Apr 4, 2024
FDA

FUROSEMIDE

Approval Date
Apr 3, 2024
FDA

ESMOLOL HYDROCHLORIDE

Approval Date
Apr 2, 2024
FDA

Midazolam

Approval Date
Apr 1, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 18
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.